These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16159966)

  • 1. Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.
    Thomas MD; Fox KF; Wood DA; Gibbs JS; Coats AJ; Henein MY; Poole-Wilson PA; Sutton GC
    Heart; 2006 May; 92(5):603-8. PubMed ID: 16159966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systolic and diastolic heart failure in the community.
    Bursi F; Weston SA; Redfield MM; Jacobsen SJ; Pakhomov S; Nkomo VT; Meverden RA; Roger VL
    JAMA; 2006 Nov; 296(18):2209-16. PubMed ID: 17090767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study.
    Jaubert MP; Armero S; Bonello L; Nicoud A; Sbragia P; Paganelli F; Arques S
    Arch Cardiovasc Dis; 2010 Jan; 103(1):3-9. PubMed ID: 20142114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure-a comparison with brain natriuretic peptide.
    Vinereanu D; Lim PO; Frenneaux MP; Fraser AG
    Eur J Heart Fail; 2005 Jun; 7(4):512-9. PubMed ID: 15921788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
    Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
    Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide.
    Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
    Int J Clin Pract; 2005 Aug; 59(8):891-4. PubMed ID: 16033608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization.
    Palazzuoli A; Beltrami M; Ruocco G; Franci B; Campagna MS; Nuti R
    Eur J Intern Med; 2016 May; 30():43-48. PubMed ID: 26718066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.
    Maisel AS; McCord J; Nowak RM; Hollander JE; Wu AH; Duc P; Omland T; Storrow AB; Krishnaswamy P; Abraham WT; Clopton P; Steg G; Aumont MC; Westheim A; Knudsen CW; Perez A; Kamin R; Kazanegra R; Herrmann HC; McCullough PA;
    J Am Coll Cardiol; 2003 Jun; 41(11):2010-7. PubMed ID: 12798574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
    Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Saudi Med J; 2005 Nov; 26(11):1695-8. PubMed ID: 16311650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department.
    Karakiliç E; Kepez A; Abali G; Coşkun F; Kunt M; Tokgözoğlu L
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):143-9. PubMed ID: 20382614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
    Feola M; Aspromonte N; Canali C; Ceci V; Giovinazzo P; Milani L; Quarta G; Ricci R; Scardovi AB; Uslenghi E; Valle R
    Am J Cardiol; 2005 Sep; 96(5):705-9. PubMed ID: 16125500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy].
    Elbl L; Vásová I; Navrátil M; Vorlícek J; Malásková L; Spinar J
    Vnitr Lek; 2006 Jun; 52(6):563-70. PubMed ID: 16871759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.
    Aspromonte N; Feola M; Scardovi AB; Coletta C; D'Eri A; Giovinazzo P; Carunchio A; Chiera A; Fanelli R; Di Giacomo T; Ricci R; Ceci V; Milani L; Valle R
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):406-13. PubMed ID: 16721202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.
    Troughton RW; Prior DL; Pereira JJ; Martin M; Fogarty A; Morehead A; Yandle TG; Richards AM; Starling RC; Young JB; Thomas JD; Klein AL
    J Am Coll Cardiol; 2004 Feb; 43(3):416-22. PubMed ID: 15013124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
    J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress.
    Maeder MT; Mariani JA; Kaye DM
    Hypertension; 2010 Oct; 56(4):682-9. PubMed ID: 20713912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
    Kocaman SA; Taçoy G; Ozdemir M; Açıkgöz SK; Cengel A
    Anadolu Kardiyol Derg; 2010 Dec; 10(6):519-25. PubMed ID: 20952357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.